Within a short span of just 5 years, Mynvax is recognized as a highly promising vaccine developer, thanks in part to several partnerships the Company has built to advance its vaccine development program.
The Society for Innovation and Development (SID) is focused on nurturing technology start-ups with the expert knowledge capital of IISc, to help achieve societal impact through science. ...
Prof. Raghavan Varadarajan, co-founder Mynvax, is a Professor at the Molecular Biophysics Unit, Indian Institute of Science. His laboratory ...
The Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit public sector enterprise set up by the Department of Biotechnology (DBT), Government of India. ...
ENDFLU is a consortium of 14 leading laboratories from India and the European Union working on development of next-generation influenza vaccine candidates ...